USCWA
PGEN icon

U.S. Capital Wealth Advisors’s Precigen PGEN Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-425
Closed -$646 – 1267
2022
Q4 		$646 Buy
+425
New +$731 ﹤0.01% 1558

Other funds holding PGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

U.S. Capital Wealth Advisors's PGEN Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Precigen (PGEN) in Q1 2023, closing a stake of 425 shares — an estimated $646 sold.

U.S. Capital Wealth Advisors first reported a position in PGEN in Q4 2022 and held it in 1 quarter. The position peaked at $646 in Q4 2022. 157 funds tracked by Wall St. Rank hold PGEN as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Precigen position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 425 Precigen shares in Q1 2023, an estimated $646.
  • U.S. Capital Wealth Advisors first reported a position in Precigen in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Precigen position peaked at $646 in Q4 2022.
  • 157 funds tracked by Wall St. Rank held Precigen as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.